1. Home
  2. IPG vs GRFS Comparison

IPG vs GRFS Comparison

Compare IPG & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPG
  • GRFS
  • Stock Information
  • Founded
  • IPG 1902
  • GRFS 1940
  • Country
  • IPG United States
  • GRFS Spain
  • Employees
  • IPG N/A
  • GRFS N/A
  • Industry
  • IPG Advertising
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • IPG Consumer Discretionary
  • GRFS Health Care
  • Exchange
  • IPG Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • IPG 8.9B
  • GRFS 7.2B
  • IPO Year
  • IPG N/A
  • GRFS 2006
  • Fundamental
  • Price
  • IPG $26.48
  • GRFS $9.59
  • Analyst Decision
  • IPG Buy
  • GRFS Hold
  • Analyst Count
  • IPG 7
  • GRFS 1
  • Target Price
  • IPG $31.59
  • GRFS $10.30
  • AVG Volume (30 Days)
  • IPG 5.5M
  • GRFS 865.0K
  • Earning Date
  • IPG 10-21-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • IPG 5.00%
  • GRFS 1.47%
  • EPS Growth
  • IPG N/A
  • GRFS 132.60
  • EPS
  • IPG 1.18
  • GRFS 0.53
  • Revenue
  • IPG $8,846,600,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • IPG N/A
  • GRFS $6.00
  • Revenue Next Year
  • IPG $2.79
  • GRFS $6.71
  • P/E Ratio
  • IPG $22.31
  • GRFS $24.23
  • Revenue Growth
  • IPG N/A
  • GRFS 9.32
  • 52 Week Low
  • IPG $22.51
  • GRFS $6.19
  • 52 Week High
  • IPG $33.05
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • IPG 55.49
  • GRFS 35.93
  • Support Level
  • IPG $26.42
  • GRFS $9.79
  • Resistance Level
  • IPG $27.02
  • GRFS $9.99
  • Average True Range (ATR)
  • IPG 0.47
  • GRFS 0.20
  • MACD
  • IPG -0.03
  • GRFS -0.11
  • Stochastic Oscillator
  • IPG 50.00
  • GRFS 1.96

About IPG Interpublic Group of Companies Inc. (The)

Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services such as public relations through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe. IPG agreed to merge with Omnicom in December 2024, pending regulatory approval.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: